Syndecan-1 regulates αvβ3 and αvβ5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitorDeannaLee M. Beauvais, Alan C. Rapraeger|The Journal of Experimental Medicine|2009Cited by 278
Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatinsOisun Jung, Alan C. Rapraeger|Oncogenesis|2016Cited by 111
Interaction of Syndecan and α6β4 Integrin Cytoplasmic DomainsHaiyao Wang, Alan C. Rapraeger|Journal of Biological Chemistry|2010Cited by 67
Syndecans and Their Synstatins: Targeting an Organizer of Receptor Tyrosine Kinase Signaling at the Cell-Matrix InterfaceAlan C. Rapraeger|Frontiers in Oncology|2021Cited by 18
Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progressionDeannaLee M. Beauvais, Alan C. Rapraeger|Journal of Biological Chemistry|2022Cited by 10